fenofibrate
Commercial- Indications
- Hyperlipidemia, Mixed dyslipidemia
Company intelligence / Profile preview
ProEthic Pharmaceuticals
Montgomery, Alabama, United Statesjustdial.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
ProEthic’s lead product was Lipofen® for lipid disorders, marketed in the U.S. via a licensing agreement with Cipher Pharmaceuticals. The company also developed diclofenac-based products for acute migraine and pain management—one of which had an NDA under FDA review at the time of its transition to Kowa ownership. After acquisition by Kowa Company, Ltd., ProEthic’s pipeline and operations were integrated into the new entity focused on cardiometabolic therapeutics.
- Therapeutic areas
- CardiovascularNeurology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Cipher Pharmaceuticals Inc.—exclusive U.S. marketing/distribution rights for Lipofen®.
Beyond the preview
Go deeper on ProEthic Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ProEthic Pharmaceuticals.